Finance

Lists
ENSG:NASDAQ
The Ensign Group, Inc.
$175.18
+1.10%
(+1.90) 1D
Sep 25, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENSG...
Open
$172.51
High
$175.28
Low
$172.51
Mkt. cap
10.21B
Avg. vol.
333.07K
Volume
0.00
Dividend
0.15%
Quarterly dividend
$0.07
Ex-dividend date
Sep 30, 2026
P/E ratio
27.46
52-wk high
$218.00
52-wk low
$141.58
EPS
$6.38
Beta
0.69
Shares outstanding
58.28M
No. of employees
46K
Open
$172.51
High
$175.28
Low
$172.51
Mkt. cap
10.21B
Avg. vol.
333.07K
Volume
0.00
Dividend
0.15%
Quarterly dividend
$0.07
Ex-dividend date
Sep 30, 2026
P/E ratio
27.46
52-wk high
$218.00
52-wk low
$141.58
EPS
$6.38
Beta
0.69
Shares outstanding
58.28M
No. of employees
46K
News stories
From web sources and news partners
About The Ensign Group, Inc.
CEOBarry R. Port
Employees46K
Founded1999
Headquarters-
SectorHealth care provider
Websiteensigngroup.net
Analyst ratings
Based on 3 analysts giving stock ratings to ENSG in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ENSG in the last 3 months.
Highest
Current $175.18
$228.00 (+30.15%)
Average
$215.00 (+22.73%)
Lowest
$207.00 (+18.16%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Wiederhorn
Oppenheimer
Buy
Maintained
$210.00
+19.9%
09/22/2026
David S Macdonald
Truist Financial
Hold
Maintained
$207.00
+18.2%
07/30/2026
Ben Hendrix
RBC Capital
Buy
Maintained
$228.00
+30.2%
07/27/2026
Unknown Analyst
Stephens
Buy
Maintained
$225.00
+28.4%
06/15/2026
A.J. Rice
UBS
Buy
Maintained
$230.00
+31.3%
02/06/2026
Last report
Jul 29, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$1.92 / $1.85
+4.02%beat
Revenue / Est. (USD)
1.44B / 1.44B
-0.06%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.30B
1.36B
1.39B
1.44B
Cost of goods sold
1.10B
1.13B
1.15B
1.19B
Cost of revenue
1.10B
1.13B
1.15B
1.19B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
74.15M
77.79M
81.19M
86.20M
Operating expense
100.79M
105.51M
109.99M
117.61M
Total operating expenses
1.20B
1.24B
1.26B
1.31B
Operating income
96.22M
123.81M
124.85M
130.14M
Other non operating income
3.75M
2.00M
-885.00K
830.00K
EBT including unusual items
106.60M
130.08M
128.57M
133.67M
EBT excluding unusual items
104.16M
130.08M
128.57M
133.67M
Income tax expense
22.69M
34.55M
28.82M
33.84M
Effective tax rate
21.28%
26.56%
22.41%
25.32%
Other operating expenses
-
-
-
-
Net income
83.84M
95.45M
99.67M
99.74M
Net profit margin
6.47%
7.02%
7.17%
6.92%
Earnings per share
1.64
1.82
1.85
1.92
Interest and investment income
6.17M
6.22M
6.54M
4.63M
Interest expense
-1.97M
-1.96M
-1.93M
-1.93M
Net interest expenses
4.20M
4.27M
4.60M
2.70M
Depreciation and amortization charges
26.63M
27.72M
28.80M
31.41M
EBITDA
122.58M
151.26M
153.38M
161.82M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps